Nucleosyn
  • Home
  • Products
    • All products
    • Products categories
    • DNA-RNA
    • Synthetic lipids
    • Stable isotope
    • Custom chemical synthesis
  • Capabilities
  • About Us
  • Contact
  • Linkedin

My selection

Stable isotope

Nucleosyn provides Custom Stable Isotope (2H, 13C, 15N) compounds to support projects dedicated to : Bioanalytics, Omics research, Molecular Imaging, and Biomarker discovery.

[13C6]-Belinostat

CAS #
N/A
Packing size
5mg, 10mg, 25mg, bulk
Anticancer drugSILTherapeutic Drug Monitoring (TDM)
-Belinostat Image 1

Belinostat is a histone deacetylase inhibitor used to treat hematological malignancies and solid tumors. It also has been approved in the US for treating peripheral T-cell lymphoma.

Stable isotope labeled [13C6]-Belinostat is intended for use as an internal standard for the quantification of Belinostat by LC or GC-mass spectrometry.

Aspect
White solid
Purity
Chemical purity 95%; Isotopic Enrichment 98%
Solubility
DMSO, EtOH (heat to 60°C)
Molecular weight
324.30
Molecular formula

C913C6H14N2O4S

IUPAC
(E)-N-hydroxy-3-(3-(N-(phenyl-13C6)sulfamoyl)phenyl)acrylamide

M. Briki et al., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2024, 1236, 124039. (read article)

B. F. Kiesel et al., J. Pharm. Biomed. Anal., 2013, 81-82, 89-98. (read article)

Purchase [13C6]-Belinostat

Get a quote on this product

We're ready to solve any rare chemicals sourcing or molecular design problem... Give us a shout! Please fill out this form completely.

If you don't find a product in our current offer, please don't hesitate to request a quote using our contact form.

Add to my selection

Related products

Macimorelin acetate
CAS #
945212-59-9
Details
Ribociclib
CAS #
1211441-98-3
Details
[13C6]-Glucosylsphingosine ([13C6]-GlSph...
CAS #
299172-48-8
Details
See more products

logo footerNucleosyn

111 Bd Duhamel du Monceau

45160 Olivet

Products

See Catalog

Know more about products

Contact

Contact Form

+33 2 38 49 45 73

Follow us

Other Infos

Legal notices

Privacy Policy & cookies infos

General terms & conditions

© Nucleosyn 2026 - All rights reserved

Design and development Think Ad Communication